Opioid antagonists. I: Pharmacology and rationale for use in treating self-injury Yadhu N. SinghRobert W. RickettsNirhay N. Singh OriginalPaper Pages: 5 - 15
Opioid antagonists. II: Clinical effects in the treatment of self-injury in individuals with developmental disabilities Robert W. RickettsCynthia R. EllisNirbhay N. Singh OriginalPaper Pages: 17 - 28
Naltrexone improves learning and attention in self-injurious individuals with developmental disabilities Derek V. TaylorCurt A. SandmanJennifer L. Barron OriginalPaper Pages: 29 - 42
Effects of chlorpromazine and thioridazine on discrimination learning in children with mental retardation Ivan L. BealeOwen A. SmithDonald M. Webster OriginalPaper Pages: 43 - 54
Classification of types of tardive dyskinesia in a developmentally disabled population at a public residential facility Tim WigalDiane L. ChristianDonald B. Dean OriginalPaper Pages: 55 - 69
Assessing environmental and medication variables in an outpatient setting: A proposed model and preliminary results with ADHD Children Linda J. CooperDavid P. WackerLynn Rogers OriginalPaper Pages: 71 - 85
Pharmacotherapy of aggressive behavior in individuals with mental retardation and mental illness Larry WilliamsCynthia R. EllisYadhu N. Singh OriginalPaper Pages: 87 - 94